Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000671115 | SCV000796060 | likely pathogenic | Retinitis pigmentosa 26 | 2017-11-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000671115 | SCV000894245 | likely pathogenic | Retinitis pigmentosa 26 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000779293 | SCV000915875 | likely pathogenic | Retinitis pigmentosa | 2024-09-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000794851 | SCV000934284 | pathogenic | not provided | 2025-01-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg461*) in the CERKL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CERKL are known to be pathogenic (PMID: 14681825, 23591405, 24043777). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa (PMID: 28559085). ClinVar contains an entry for this variant (Variation ID: 555316). For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001074698 | SCV001240291 | pathogenic | Retinal dystrophy | 2019-04-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000794851 | SCV001248800 | pathogenic | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000794851 | SCV001447690 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000671115 | SCV004211593 | pathogenic | Retinitis pigmentosa 26 | 2023-12-05 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001074698 | SCV005070295 | pathogenic | Retinal dystrophy | 2023-01-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000671115 | SCV001463762 | pathogenic | Retinitis pigmentosa 26 | 2020-09-16 | no assertion criteria provided | clinical testing |